VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 111 filers reported holding VOYAGER THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $102,781 | -94.0% | 13,262 | -91.2% | 0.00% | -100.0% |
Q2 2023 | $1,717,821 | +128.4% | 150,028 | +18.1% | 0.01% | -57.1% |
Q3 2022 | $752,000 | +227.0% | 127,014 | +226.5% | 0.01% | +133.3% |
Q2 2022 | $230,000 | -80.0% | 38,906 | -74.2% | 0.01% | -80.6% |
Q1 2022 | $1,148,000 | +2633.3% | 150,667 | +837.6% | 0.03% | +3000.0% |
Q3 2021 | $42,000 | – | 16,069 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 7,891,176 | $154,194,000 | 51.35% |
Trustees of Princeton University | 203,638 | $3,979,000 | 4.13% |
Casdin Capital, LLC | 1,135,000 | $22,178,000 | 3.10% |
GREAT POINT PARTNERS LLC | 730,010 | $14,264,000 | 1.98% |
BB BIOTECH AG | 2,532,641 | $49,488,000 | 1.43% |
Aevitas Wealth Management, Inc. | 73,323 | $1,433,000 | 1.40% |
Patriot Financial Group Insurance Agency, LLC | 64,256 | $1,256,000 | 1.34% |
Virtus ETF Advisers LLC | 37,502 | $733,000 | 0.65% |
Eventide Asset Management | 703,425 | $13,745,000 | 0.57% |
THOMPSON DAVIS & CO., INC. | 11,951 | $234,000 | 0.56% |